Wellington Management Group LLP Instil Bio, Inc. Transaction History

Wellington Management Group LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.48 - $5.33 $483 - $5,367	-1,007 Reduced 0.42%	237,427 $149,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $1.11 Million - $1.76 Million	238,434 New	238,434 $1.15 Million
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $3.63 Million - $9.62 Million	-862,926 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$8.48 - $18.1 $15.2 Million - $32.5 Million	-1,793,708 Reduced 67.52%	862,926 $9.28 Million
Q4 2021 Feb 11, 2022	SELL	$15.37 - $22.5 $7.66 Million - $11.2 Million	-498,521 Reduced 15.8%	2,656,634 $45.5 Million
Q2 2021 Aug 16, 2021	SELL	$15.31 - $24.63 $25.3 Million - $40.7 Million	-1,650,990 Reduced 34.35%	3,155,155 $59.7 Million
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $116 Million - $130 Million	4,806,145 New	4,806,145 $117 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.